Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

OUTLOOK THERAPEUTICS INC

OTLK
Current price
5.51 USD -0.51 USD (-8.47%)
Last closed 6.27 USD
ISIN US69012T2069
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 149 503 392 USD
Yield for 12 month -38.26 %
1Y
3Y
5Y
10Y
15Y
OTLK
21.11.2021 - 28.11.2021

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with BioLexis Pte. Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. Address: Building F, Iselin, NJ, United States, 08852

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

39.23 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-44 188 USD

Last Year

-204 694 USD

Current Quarter

-28 672 USD

Last Quarter

-28 195 USD

Key Figures OTLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -61 188 524 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -83.69 %
PEG Ratio
Return On Equity TTM -3.65 %
Wall Street Target Price 39.23 USD
Revenue TTM 5 853 537 USD
Book Value -3.58 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 658.3 %
Dividend Yield
Gross Profit TTM -42 330 856 USD
Earnings per share -5.89 USD
Diluted Eps TTM -5.89 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics OTLK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OTLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 14.03.2024
Dividend Date 18.03.2019

Stock Valuation OTLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2.8498
Enterprise Value Revenue 26.101
Price Sales TTM 13.2716
Enterprise Value EBITDA -4.1278
Price Book MRQ 10.1912

Financials OTLK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OTLK

For 52 weeks

4.61 USD 12.85 USD
50 Day MA 5.93 USD
Shares Short Prior Month 2 947 927
200 Day MA 7.48 USD
Short Ratio 10.99
Shares Short 2 989 293
Short Percent 18.6 %